![Rivaroxaban for stroke prevention in people with atrial fibrillation and diabetes mellitus - Li - 2018 - Diabetic Medicine - Wiley Online Library Rivaroxaban for stroke prevention in people with atrial fibrillation and diabetes mellitus - Li - 2018 - Diabetic Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/68a8d043-09ab-4c6f-bd36-885f97e5efc2/dme.2018.35.issue-8.cover.jpg?trick=1679294441865)
Rivaroxaban for stroke prevention in people with atrial fibrillation and diabetes mellitus - Li - 2018 - Diabetic Medicine - Wiley Online Library
![Rivaroxaban compared with low-dose aspirin in individuals with type 2 diabetes and high cardiovascular risk: a randomised trial to assess effects on endothelial function, platelet activation and vascular biomarkers | SpringerLink Rivaroxaban compared with low-dose aspirin in individuals with type 2 diabetes and high cardiovascular risk: a randomised trial to assess effects on endothelial function, platelet activation and vascular biomarkers | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00125-021-05562-9/MediaObjects/125_2021_5562_Figa_HTML.png)
Rivaroxaban compared with low-dose aspirin in individuals with type 2 diabetes and high cardiovascular risk: a randomised trial to assess effects on endothelial function, platelet activation and vascular biomarkers | SpringerLink
Effectiveness and Safety of Apixaban versus Rivaroxaban in Patients with Atrial Fibrillation and Type 2 Diabetes Mellitus
Healthcare Resource Utilization and Costs of Rivaroxaban Versus Warfarin Among Non-valvular Atrial Fibrillation (NVAF) Patients with Diabetes in a US Population,Advances in Therapy - X-MOL
![Effectiveness and Safety of Standard- and Low-Dose Rivaroxaban in Asians With Atrial Fibrillation | Journal of the American College of Cardiology Effectiveness and Safety of Standard- and Low-Dose Rivaroxaban in Asians With Atrial Fibrillation | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/4a261a66-43fe-4c91-8816-e0f3b72db49e/fx1.jpg)
Effectiveness and Safety of Standard- and Low-Dose Rivaroxaban in Asians With Atrial Fibrillation | Journal of the American College of Cardiology
![Thromboembolism, bleeding and vascular death in nonvalvular atrial fibrillation patients with type 2 diabetes receiving rivaroxaban or warfarin | Cardiovascular Diabetology | Full Text Thromboembolism, bleeding and vascular death in nonvalvular atrial fibrillation patients with type 2 diabetes receiving rivaroxaban or warfarin | Cardiovascular Diabetology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12933-021-01250-5/MediaObjects/12933_2021_1250_Fig1_HTML.png)
Thromboembolism, bleeding and vascular death in nonvalvular atrial fibrillation patients with type 2 diabetes receiving rivaroxaban or warfarin | Cardiovascular Diabetology | Full Text
![The Safety and Efficacy of Rivaroxaban Compared with Warfarin in Patients with Atrial Fibrillation and Diabetes: A Systematic Review and Meta-analysis | SpringerLink The Safety and Efficacy of Rivaroxaban Compared with Warfarin in Patients with Atrial Fibrillation and Diabetes: A Systematic Review and Meta-analysis | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40256-020-00407-z/MediaObjects/40256_2020_407_Fig3_HTML.png)
The Safety and Efficacy of Rivaroxaban Compared with Warfarin in Patients with Atrial Fibrillation and Diabetes: A Systematic Review and Meta-analysis | SpringerLink
Thesis | Effectiveness and safety of apixaban versus rivaroxaban in patients with nonvalvular atrial fibrillation and type 2 diabetes mellitus | ID: ks65hj13f | eScholarship@McGill
![Selection criteria. Application of the selection criteria yielded more... | Download Scientific Diagram Selection criteria. Application of the selection criteria yielded more... | Download Scientific Diagram](https://www.researchgate.net/publication/341087181/figure/fig1/AS:886505753034753@1588370850294/Selection-criteria-Application-of-the-selection-criteria-yielded-more-than-100-000.png)
Selection criteria. Application of the selection criteria yielded more... | Download Scientific Diagram
![PDF) Thromboembolism, bleeding and vascular death in nonvalvular atrial fibrillation patients with type 2 diabetes receiving rivaroxaban or warfarin PDF) Thromboembolism, bleeding and vascular death in nonvalvular atrial fibrillation patients with type 2 diabetes receiving rivaroxaban or warfarin](https://www.researchgate.net/publication/349643528/figure/fig1/AS:995697931329542@1614404294446/Selection-of-patients_Q320.jpg)
PDF) Thromboembolism, bleeding and vascular death in nonvalvular atrial fibrillation patients with type 2 diabetes receiving rivaroxaban or warfarin
![JCM | Free Full-Text | A Systematic Review of the Efficacy and Safety of Direct Oral Anticoagulants in Atrial Fibrillation Patients with Diabetes Using a Risk Index JCM | Free Full-Text | A Systematic Review of the Efficacy and Safety of Direct Oral Anticoagulants in Atrial Fibrillation Patients with Diabetes Using a Risk Index](https://www.mdpi.com/jcm/jcm-10-02924/article_deploy/html/images/jcm-10-02924-g004.png)
JCM | Free Full-Text | A Systematic Review of the Efficacy and Safety of Direct Oral Anticoagulants in Atrial Fibrillation Patients with Diabetes Using a Risk Index
![Bayer's Xarelto confirms benefits for type 2 diabetics with atrial fibrillation < Pharma < Article - KBR Bayer's Xarelto confirms benefits for type 2 diabetics with atrial fibrillation < Pharma < Article - KBR](https://cdn.koreabiomed.com/news/photo/202105/11220_11473_836.jpg)
Bayer's Xarelto confirms benefits for type 2 diabetics with atrial fibrillation < Pharma < Article - KBR
![Rivaroxaban does not influence hemorrhagic transformation in a diabetes ischemic stroke and endovascular thrombectomy model | Scientific Reports Rivaroxaban does not influence hemorrhagic transformation in a diabetes ischemic stroke and endovascular thrombectomy model | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-25820-y/MediaObjects/41598_2018_25820_Fig1_HTML.jpg)